By 2050, construction's carbon footprint may double, jeopardizing climate targets. Transitioning to low-carbon materials is ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or the "Company"), a leader in the development of differentiated targeted radiotherapies, announced today that new preclinical data for ...